A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

NCT05787574 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Primary Immune Regulatory Disorder
Autoimmune Lymphoproliferative
Immune System Diseases

Interventions

DRUG: Emapalumab
DRUG: Fludarabine and Dexamethasone
PROCEDURE: Stem Cell Transplant

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]